Draft guidelines reject NHS funding for Biogen’s Spinraza

14th August 2018 Uncategorised 0

The National Institute for Health and Care Excellence is not recommending NHS use of Biogen’s Spinraza for the rare genetic disorder spinal muscular atrophy (SMA) at this time.

More: Draft guidelines reject NHS funding for Biogen’s Spinraza
Source: News